- Behavioral health and addiction treatment
- Dental health plans
- Dental practice management
- Disease management
- Health intelligence and technology
- Home nursing and homecare
- In-clinic pharmacy network
- Insurance third party administrator (TPA) services
- Radiology dept. management
- Medical staffing
- Medical transcription
- Pediatric therapy
- Physician practice management
- Self-funded healthcare benefit plans
- Specialty surgery management
- Urgent care
- Analytical labs and preclinical services
- Clinical operations
- Clinical research sites
- Contract research organizations
- Health economics consulting
- Medical education and marketing
- Particle processing and finished dose manufacturing
- Regulatory affairs consulting
- Sterile injectable contract manufacturing
Medical Products Manufacturing & Distribution
- Acute care medical supplies
- Contract manufacturing
- Custom procedure trays
- Disposable medical protective apparel and supplies
- Durable medical equipment
- Medical device research and development
- Orthopedic bracing & support products
- Private label OTC manufacturing
- Surgical face masks and PPE
Note: Some transactions were completed by principals while employed by previous firms.
Biopharmaceutical Regulatory Consulting
Dunn Regulatory Associates Sold to Acacium Group, a Portfolio Company of Onex
Dunn Regulatory Associates LLC
Dunn Regulatory Associates (DRA) is a U.S.-based life sciences and regulatory affairs consulting company that serves a diverse, global client base of pharmaceutical, biotech, and medical device companies. DRA’s comprehensive regulatory services include regulatory strategy, medical writing, regulatory publishing, and U.S. Agent services. Using an experience-based approach that integrates scientific expertise, business acumen, and regulatory strategy, DRA streamlines product development from discovery to market. DRA’s expert consultants are U.S. and EU strategists, who have a proven track record of resolving complex regulatory situations.
Sold to Acacium Group, a portfolio company of Onex
Pharmaceutical Clinical Trial Services
Catalyst Clinical Research Sold to NovaQuest Capital Management
Catalyst Clinical Research
Catalyst Clinical Research is a niche contract research organization (CRO) that specializes in providing highly tailored clinical operations solutions to the global biopharmaceutical and medical device industries. Catalyst enables clinical trial sponsors to rapidly and cost‐effectively access therapeutically aligned teams and individual resources on an as needed basis as an alternative or adjunct to traditional CRO services. The company’s professionals cover all clinical operations functions, including clinical trial monitoring, project management, study startup/regulatory, quality assurance, and medical writing. Catalyst’s clinical study experience spans all major therapeutic areas and phases (I-IV) of the drug development process. Catalyst is headquartered in the U.S. with operations in Europe.
Sold to NovaQuest Capital Management
Surgical Face Masks and PPE
Precept Medical Products Sold to Aspen Surgical, a Portfolio Company of Audax Group
Precept Medical Products, Inc.
Precept designs, manufactures, and markets nonwoven, single-use disposable protective medical apparel that addresses infection control challenges faced by healthcare professionals. The company is a leader in the U.S. surgical face mask market with its high-quality Fogshield® brand, and also offers a full line of procedure face masks, non-surgical isolation gowns, lab jackets, scrubs, coveralls, patient gowns, lab coats, and cold therapy packs. Precept is headquartered in Arden, North Carolina, and has manufacturing and distribution operations in Agua Prieta, Mexico, and Douglas, Arizona, respectively. Precept has demonstrated a consistent track record of driving revenue growth through its diverse customer base, producing close to 100 million disposable face masks and 13 million isolation gowns annually.
Sold to Aspen Surgical, a portfolio company of Audax Group
Collegiate Addiction Treatment*
The Ranch at Dove Tree Sold to Summit BHC, a Portfolio Company of Flexpoint Ford
The Ranch at Dove Tree
The Ranch at Dove Tree (RDT) is one of the nation’s leaders in collegiate-focused addiction and behavioral health comprehensive treatment with recovery resiliency services. RDT specializes in alcohol and drug addiction with co-occurring issues such as depression, anxiety, disordered eating, and trauma. Through its collaboration with Texas Tech University’s Institute for the Study of Addiction, Recovery & Families, RDT provides the premiere collegiate recovery model in the nation. The company’s full continuum of care includes detoxification, collegiate residential treatment, adult residential treatment, collegiate transitional living, and outpatient programs. RDT is located in Lubbock, Texas.
Sold to Summit BHC, a portfolio company of Flexpoint Ford
Note: Transaction completed by principal while employed by previous firm.